4//SEC Filing
Pfeiffenberger Brent 4
Accession 0002001162-25-000009
CIK 0001850119other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:38 PM ET
Size
5.2 KB
Accession
0002001162-25-000009
Insider Transaction Report
Form 4
Pfeiffenberger Brent
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-12-12$0.58/sh+52,000$30,352→ 3,322,990 total
Footnotes (2)
- [F1]All profits from the reported transactions will be disgorged to the issuer pursuant to applicable requirements.
- [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.577 to $0.5838. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0002001162
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:38 PM ET
- Size
- 5.2 KB